Copy right.

Replicate harnesses the body’s natural protein-making power and uses synthetic biology to design unique self-replicating RNAs (srRNAs) that can direct that power to fight disease.

With our customizable srRNA platform and our diverse repertoire of virally derived vectors, we are tackling drug resistance in cancers and discovering new treatments for autoimmune and inflammatory disorders and other diseases.

Replicate is working to make srRNA therapeutics broadly accessible, to realize their promise for all patients.

The Replicate
srRNA Platform

Replicate srRNA vectors deliver to cells in the body an “instruction manual” for making a therapeutic protein, along with a “copying machine” to reproduce those instructions over and over so that cells continue making the protein. Using synthetic biology, we craft customized vehicles from the srRNA that are suited to deliver different kinds of therapeutic proteins.

Our srRNA approach offers exceptional advantages in therapeutic applications:

  • Lowered dosing levels by several orders of magnitude, compared to other RNA therapeutic platforms
  • Increased duration of therapeutic effect
  • Selectively programmed ability to either activate or evade the immune system, as needed
Our Science

1.

rna enters the cell

2.

RNA Replicates and Mimics Virus

3.

RNA Translated by Body to Produce Proteins

Replicate has devised a solution to huge problems where no viable options or therapies yet exist.

Our Mission and Story

News

View All

ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE SCIENCES COMPANIES.